Status:
UNKNOWN
Elevated Stearoyl-CoA Desaturase-1 Expression Predicts the Disease Severity of Severe Acute Pancreatitis
Lead Sponsor:
Nanjing University School of Medicine
Conditions:
Acute Pancreatitis
Organ Failure, Multiple
Eligibility:
All Genders
18-75 years
Brief Summary
In this study, the investgatiors aimed to investigate the associations between serum levels of stearoyl-CoA desaturase-1（SCD-1） and the disease severity as well as the presence of adverse clinical eve...
Eligibility Criteria
Inclusion
- Diagnosis of acute pancreatitis (Atlanta standard), abdominal pain occurred within one week of admission;
- APACHEII score is more than 8 and Ranson score is greater than 3;
- Age 18-75;
- Obtaining informed consent.
Exclusion
- Pregnancy pancreatitis;
- Patients with the following disease history: severe cardiac, pulmonary, renal, liver function insufficiency or immunodeficiency disease.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2019
Estimated Enrollment :
216 Patients enrolled
Trial Details
Trial ID
NCT03282253
Start Date
January 1 2018
End Date
June 30 2019
Last Update
November 27 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.